Similarly , femoral neck bone mineral density increased more in the teriparatide to denosumab group ( 83 % [ 95 % CI 61-105 ] ) and the combination to denosumab group ( 91 % [ 61-120 ] ) than in the denosumab to teriparatide group ( 49 % [ 22-75 ] ; p = 00447 for teriparatide to denosumab vs denosumab to teriparatide , p = 00336 for combination to denosumab vs denosumab to teriparatide ) .